{"response":{"docs":[{"system_create_dtsi":"2021-10-27T21:36:51Z","system_modified_dtsi":"2021-10-28T14:11:55Z","has_model_ssim":["PublishedWork"],"id":"000129997","accessControl_ssim":["3ae2bea0-be4f-496e-800c-5270ad08206a"],"hasRelatedMediaFragment_ssim":["t435gc96m"],"hasRelatedImage_ssim":["t435gc96m"],"depositor_ssim":["batchuser@example.com"],"depositor_tesim":["batchuser@example.com"],"title_tesim":["The rising cost of medicines to the NHS :  what’s the story?"],"date_uploaded_dtsi":"2021-10-27T21:36:50Z","date_modified_dtsi":"2021-10-28T13:42:05Z","isPartOf_ssim":["admin_set/default"],"biblionumber_tesim":["129997"],"abstract_tesim":["In this briefing, we look at how much the health service spends in total on medicines, both generics and branded medicines, based on publicly available data. In recent years, spending on branded medicines has been constrained by the Pharmaceutical Price Regulation Scheme a new instalment of which is currently under negotiation. We also explore policies used to try to control growth in costs and the choices policy-makers are likely to face in the future."],"date_published_tesim":["2018"],"date_published_ssi":"2018","official_url_tesim":["https://www.kingsfund.org.uk/publications/rising-cost-medicines-nhs"],"pagination_tesim":["53p."],"place_of_publication_tesim":["London"],"creator_tesim":["McKenna, Helen","The King's Fund","Ewbank, Leo","Sullivan, Kane","Omojomolo, David"],"date_tesim":["2018"],"date_ssi":"2018","publisher_tesim":["The King's Fund"],"subject_tesim":["drug expenditure","costs","drug policy","regulation","drugs","NHS"],"thumbnail_path_ss":"/downloads/t435gc96m?file=thumbnail","suppressed_bsi":false,"actionable_workflow_roles_ssim":["admin_set/default-default-managing","admin_set/default-default-approving","admin_set/default-default-depositing"],"workflow_state_name_ssim":["deposited"],"member_ids_ssim":["t435gc96m"],"file_set_ids_ssim":["t435gc96m"],"visibility_ssi":"open","admin_set_tesim":["Default Admin Set"],"human_readable_type_tesim":["Published Work"],"read_access_group_ssim":["public"],"edit_access_group_ssim":["admin"],"edit_access_person_ssim":["batchuser@example.com"],"nesting_collection__pathnames_ssim":["000129997"],"nesting_collection__deepest_nested_depth_isi":1,"_version_":1714880632909201408,"timestamp":"2021-10-28T16:13:35.308Z","score":1.0}],"facets":[{"name":"creator_sim","items":[{"value":"Ewbank, Leo","hits":1,"label":"Ewbank, Leo"},{"value":"McKenna, Helen","hits":1,"label":"McKenna, Helen"},{"value":"Omojomolo, David","hits":1,"label":"Omojomolo, David"},{"value":"Sullivan, Kane","hits":1,"label":"Sullivan, Kane"},{"value":"The King's Fund","hits":1,"label":"The King's Fund"}],"label":"Author"},{"name":"subject_sim","items":[{"value":"NHS","hits":1,"label":"NHS"},{"value":"costs","hits":1,"label":"costs"},{"value":"drug expenditure","hits":1,"label":"drug expenditure"},{"value":"drug policy","hits":1,"label":"drug policy"},{"value":"drugs","hits":1,"label":"drugs"},{"value":"regulation","hits":1,"label":"regulation"}],"label":"Subject"},{"name":"resource_type_sim","items":[],"label":"Resource type"},{"name":"date_range_sim","items":[{"value":"2018","hits":1,"label":"2018"}],"label":"Date Range"},{"name":"file_format_sim","items":[],"label":"File format"},{"name":"member_of_collections_ssim","items":[],"label":"Collection"},{"name":"generic_type_sim","items":[{"value":"Work","hits":1,"label":"Work"}],"label":"Generic Type Sim"}],"pages":{"current_page":1,"next_page":null,"prev_page":null,"total_pages":1,"limit_value":10,"offset_value":0,"total_count":1,"first_page?":true,"last_page?":true}}}